FI944535A0 - Rapamysiinikoostumuksia oraalisesti annettaviksi - Google Patents

Rapamysiinikoostumuksia oraalisesti annettaviksi

Info

Publication number
FI944535A0
FI944535A0 FI944535A FI944535A FI944535A0 FI 944535 A0 FI944535 A0 FI 944535A0 FI 944535 A FI944535 A FI 944535A FI 944535 A FI944535 A FI 944535A FI 944535 A0 FI944535 A0 FI 944535A0
Authority
FI
Finland
Prior art keywords
oral administration
volume
rapamycin
rapamycin compositions
compositions
Prior art date
Application number
FI944535A
Other languages
English (en)
Swedish (sv)
Other versions
FI115033B (fi
FI944535A (fi
Inventor
Robert Paul Waranis
Thomas Waymond Leonard
Maureen Murphy Harrison
Christian Luther Ofslager
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of FI944535A0 publication Critical patent/FI944535A0/fi
Publication of FI944535A publication Critical patent/FI944535A/fi
Application granted granted Critical
Publication of FI115033B publication Critical patent/FI115033B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI944535A 1993-09-30 1994-09-29 Menetelmä rapamysiinikoostumuksien valmistamiseksi oraalisesti annettaviksi FI115033B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US12952993A 1993-09-30 1993-09-30
US12952393A 1993-09-30 1993-09-30
US12952993 1993-09-30
US12952393 1993-09-30

Publications (3)

Publication Number Publication Date
FI944535A0 true FI944535A0 (fi) 1994-09-29
FI944535A FI944535A (fi) 1995-03-31
FI115033B FI115033B (fi) 2005-02-28

Family

ID=26827648

Family Applications (1)

Application Number Title Priority Date Filing Date
FI944535A FI115033B (fi) 1993-09-30 1994-09-29 Menetelmä rapamysiinikoostumuksien valmistamiseksi oraalisesti annettaviksi

Country Status (13)

Country Link
EP (1) EP0648494B1 (fi)
AT (1) ATE173628T1 (fi)
AU (1) AU688782B2 (fi)
DE (2) DE10199046I1 (fi)
DK (1) DK0648494T3 (fi)
ES (1) ES2124852T3 (fi)
FI (1) FI115033B (fi)
GR (1) GR3029439T3 (fi)
HK (1) HK1010342A1 (fi)
HU (1) HU220870B1 (fi)
LU (1) LU90832I2 (fi)
NL (1) NL300055I2 (fi)
SG (1) SG47803A1 (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
DE4336434A1 (de) * 1993-10-26 1995-04-27 Hoechst Ag Pharmazeutische Zubereitung für die parenterale, enterale und dermale Verabreichung von praktisch unlöslichen Arzneistoffen und Verfahren zu ihrer Herstellung
IL129547A (en) * 1994-10-26 2001-01-11 Novartis Ag Pharmaceutical compositions comprising a macrolide and an acid
FR2736550B1 (fr) 1995-07-14 1998-07-24 Sandoz Sa Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule
GB9601120D0 (en) * 1996-01-19 1996-03-20 Sandoz Ltd Organic compounds
GB2331924A (en) * 1997-12-08 1999-06-09 Phares Pharm Res Nv Lipid compositions and their use
US6682758B1 (en) 1998-12-22 2004-01-27 The United States Of America As Represented By The Department Of Health And Human Services Water-insoluble drug delivery system
DE69924004T2 (de) * 1998-12-22 2006-02-09 United States Of America Represented By The Secretary, Department Of Health & Human Services Verabreichungssystem für wasserunlösliche arzneistoffe
EP1478648B1 (en) 2002-02-01 2014-04-30 ARIAD Pharmaceuticals, Inc. Phosphorus-containing compounds and uses thereof
WO2005110360A2 (en) * 2004-05-18 2005-11-24 Phares Pharmaceutical Research N.V. Compositions for injection
CA2635797C (en) * 2006-02-09 2015-03-31 Macusight, Inc. Stable formulations, and methods of their preparation and use
RU2707285C2 (ru) 2013-10-08 2019-11-26 ЭйАй ТЕРАПЬЮТИКС, ИНК. Рапамицин для лечения лимфангиолейомиоматоза
JP2017505789A (ja) * 2014-02-11 2017-02-23 ラム・セラピューティクス，インコーポレーテッド リンパ脈管筋腫症の治療のためのラパマイシン
HRP20230863T1 (hr) 2014-04-04 2023-11-10 AI Therapeutics, Inc. Inhalacijska formulacija rapamicina, namijenjena liječenju stanja povezanih sa starenjem
EP3209330B1 (en) 2014-10-07 2022-02-23 AI Therapeutics, Inc. An inhalable sirolimus formulation for the treatment of pulmonary hypertension

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU543727B2 (en) * 1980-06-02 1985-05-02 Ayerst Mckenna & Harrison Inc. Injectable composition of rapamycin
US5100899A (en) * 1989-06-06 1992-03-31 Roy Calne Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
GB9103430D0 (en) * 1991-02-19 1991-04-03 Smithkline Beecham Plc Novel compound
IL111003A0 (en) * 1993-09-30 1994-11-28 American Home Prod Multi-component oral rapamycin formulation

Also Published As

Publication number Publication date
AU688782B2 (en) 1998-03-19
LU90832I2 (fr) 2001-11-12
EP0648494B1 (en) 1998-11-25
DE69414810D1 (de) 1999-01-07
HUT71115A (en) 1995-11-28
DE69414810T2 (de) 1999-04-22
GR3029439T3 (en) 1999-05-28
ATE173628T1 (de) 1998-12-15
FI115033B (fi) 2005-02-28
NL300055I2 (nl) 2002-04-02
DE10199046I1 (de) 2002-01-10
HU220870B1 (en) 2002-06-29
HK1010342A1 (en) 1999-06-17
NL300055I1 (nl) 2001-12-01
FI944535A (fi) 1995-03-31
HU9402786D0 (en) 1994-12-28
ES2124852T3 (es) 1999-02-16
AU7420594A (en) 1995-04-13
DK0648494T3 (da) 1999-08-09
EP0648494A1 (en) 1995-04-19
SG47803A1 (en) 1998-04-17

Similar Documents

Publication Publication Date Title
CA2133175A1 (en) Rapamycin formulations for oral administration
FI944535A0 (fi) Rapamysiinikoostumuksia oraalisesti annettaviksi
CA2133177A1 (en) Rapamycin formulations for oral administration
FI935821A (fi) Taksaanijohdannaisten fosfonooksimetyyliestereitä
AU7026794A (en) Phosphonooxymethyl ethers of taxane derivatives
HUT66660A (en) Intermediates for producing 9-[(substituted glicyl)-amido]-6-demetyl-6-deoxy-tetracyclines and pharmaceutical compositions containing them
ATE148630T1 (de) Stabilisierte derivate von vitamin d2 und d3 enthaltende pharmazeutische zusammensetzungen
ES2148254T3 (es) Peptidos antimicrobianos ciclicos y preparacion de los mismos.
DK0559079T3 (da) Substituerede aminophosphonatderivater, fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende derivaterne
IL101839A0 (en) Peptide compounds,processes for the preparation thereof,and pharmaceutical compositions containing the same
HUT68958A (en) Arylidene-1-azacycloalkane and aryl-alkyl-1-azacycloalkane derivatives their salts, pharmaceutical compositions containing them, and their preparation
IL107141A0 (en) Phospholipid derivatives containing higher elements of the vth main group,their preparation and pharmaceutical compositions containing them
FR2701477B1 (fr) Nouveaux composés (cyclohexyl)alcéniques, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.
FR2691967B1 (fr) Nouveaux composes pyrrolothienopyraziniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
AU4431493A (en) Antirheumatic composition

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 115033

Country of ref document: FI

SPCF Supplementary protection certificate application filed

Spc suppl protection certif: L20050020

SPCG Supplementary protection certificate granted

Spc suppl protection certif: 263

Extension date: 20150926

MM Patent lapsed